Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

101.26
Delayed Data
As of Aug 16
 +1.26 / +1.26%
Today’s Change
92.28
Today|||52-Week Range
137.17
-3.81%
Year-to-Date
No recent news for Taro Pharmaceutical Industries Ltd.

Today’s Trading

Previous close100.00
Today’s open100.59
Day’s range100.05 - 101.86
Volume133,485
Average volume (3 months)87,960
Market cap$4.1B
Dividend yield--
Data as of 08/16/2017

Growth & Valuation

Earnings growth (last year)-12.51%
Earnings growth (this year)-14.10%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-7.51%
P/E ratio--
Price/Sales5.48
Price/Book1.96

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc-5.40-0.66%
AKRXAkorn Inc-0.04-0.12%
ACADACADIA Pharmaceutica...-0.72-2.24%
CTLTCatalent Inc-0.01-0.03%
Data as of 08/16/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$879.4M
Annual profit (last year)$456.4M
Net profit margin51.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer
Uday Vijaykumar Baldota
Vice President &
Operations Head-Haifa
Itamar Karsenti
Corporate headquarters
Haifa Bay, Haifa

Forecasts